Breaking the Last Chains of Poliovirus Transmission: Progress and Challenges in Global Polio Eradication
- 29 September 2018
- journal article
- research article
- Published by Annual Reviews in Annual Review of Virology
- Vol. 5 (1) , 427-451
Abstract
Since the launch of the Global Polio Eradication Initiative (GPEI), paralytic cases associated with wild poliovirus (WPV) have fallen from ∼350,000 in 1988 to 22 in 2017. WPV type 2 (WPV2) was last detected in 1999, WPV3 in 2012, and WPV1 appeared to be localized to Pakistan and Afghanistan in 2017. Through continuous refinement, the GPEI has overcome operational and biological challenges far more complex and daunting than originally envisioned. Operational challenges had led to sustained WPV endemicity in core reservoirs and widespread dissemination to polio-free countries. The biological challenges derive from intrinsic limitations to the oral poliovirus vaccine: ( a) reduced immunogenicity in high-risk settings and ( b) genetic instability, leading to repeated outbreaks of circulating vaccine-derived polioviruses and prolonged infections in individuals with primary immunodeficiencies. As polio eradication enters its multifaceted endgame, the GPEI, with its technical, operational, and social innovations, stands as the preeminent model for control of vaccine-preventable diseases worldwide.Keywords
This publication has 96 references indexed in Scilit:
- Multiple Independent Emergences of Type 2 Vaccine-Derived Polioviruses during a Large Outbreak in Northern NigeriaJournal of Virology, 2013
- Reaching the last one per cent: progress and challenges in global polio eradicationCurrent Opinion in Virology, 2012
- From Emergence to Eradication: The Epidemiology of Poliomyelitis DeconstructedAmerican Journal of Epidemiology, 2010
- Genetic Inactivation of Poliovirus Infectivity by Increasing the Frequencies of CpG and UpA Dinucleotides within and across Synonymous Capsid Region CodonsJournal of Virology, 2009
- Limited duration of vaccine poliovirus and other enterovirus excretion among human immunodeficiency virus infected children in KenyaBMC Infectious Diseases, 2009
- Rapid Group-, Serotype-, and Vaccine Strain-Specific Identification of Poliovirus Isolates by Real-Time Reverse Transcription-PCR Using Degenerate Primers and Probes Containing Deoxyinosine ResiduesJournal of Clinical Microbiology, 2009
- Recombination between Polioviruses and Co-Circulating Coxsackie A Viruses: Role in the Emergence of Pathogenic Vaccine-Derived PoliovirusesPLOS Pathogens, 2009
- Calibration of Multiple Poliovirus Molecular Clocks Covering an Extended Evolutionary RangeJournal of Virology, 2008
- Rational Design of Genetically Stable, Live-Attenuated Poliovirus Vaccines of All Three Serotypes: Relevance to Poliomyelitis EradicationJournal of Virology, 2006
- Factors Affecting the Immunogenicity of Oral Poliovirus Vaccine in Developing Countries: ReviewClinical Infectious Diseases, 1991